Amid rising global anxiety on the shortage of vaccines, the National Agency for Food, Drug Administration and Control, NAFDAC, has approved two more COVID-19 vaccines for use in Nigeria.
Moderna and the Sputnik vaccines were both approved for emergency use.
The Director-General of NAFDAC, Professor Moji Adeyeye at a news conference in Abuja today explained that although the Sputnik vaccine has not yet been approved by the World Health Organisation, NAFDAC has carried out independent checks on the vaccine and found that the benefits outweigh the risks.
The National Primary Health Care Development Agency has disclosed that 4,024,000 doses of Oxford/AstraZeneca vaccine were received in Nigeria in March 2021; 3.924 million through the COVAX facility and another 100,000 doses from the Government of India.
The agency also noted that Nigeria had reported cases of mild, moderate and severe reactions, 125 severe AEFI cases were reported while 13,663 mild to moderate cases were reported.
The Federal Government has concluded plans to procure 29,850,000 doses of Johnson & Johnson (Janssen) COVID-19 vaccine while expecting additional allocation of 3,924,000 doses of AstraZeneca/AZD1222 vaccine, which according to the supply forecast, will be available for delivery into the country by July/August 2021.